This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Acreage Holdings Past Earnings Performance

Past criteria checks 0/6

Acreage Holdings has been growing earnings at an average annual rate of 20.8%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 19.4% per year.

Key information

20.8%

Earnings growth rate

27.0%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate19.4%
Return on equityn/a
Net Margin-56.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Acreage Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:0VZ1 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24177-99800
30 Jun 24194-87830
31 Mar 24213-82830
31 Dec 23223-69870
30 Sep 23228-133960
30 Jun 23233-1481020
31 Mar 23236-1421050
31 Dec 22237-1401070
30 Sep 22238-851060
30 Jun 22224-751010
31 Mar 22207-681010
31 Dec 21189-63990
30 Sep 21162-601220
30 Jun 21146-881310
31 Mar 21129-1221480
31 Dec 20115-2871860
30 Sep 20104-3001970
30 Jun 2095-2982180
31 Mar 2085-2992280
31 Dec 1974-1502010
30 Sep 1963-1251630
30 Jun 1947-991240
31 Mar 1932-47780
31 Dec 1821-27470
30 Sep 1813-8310
30 Jun 1893170
31 Mar 188-11130
31 Dec 178-9100
31 Dec 164-230

Quality Earnings: 0VZ1 is currently unprofitable.

Growing Profit Margin: 0VZ1 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0VZ1 is unprofitable, but has reduced losses over the past 5 years at a rate of 20.8% per year.

Accelerating Growth: Unable to compare 0VZ1's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0VZ1 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (25.4%).


Return on Equity

High ROE: 0VZ1's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/09 18:05
End of Day Share Price 2024/12/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Acreage Holdings, Inc. is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matt BottomleyCanaccord Genuity
Pablo ZuanicCantor Fitzgerald & Co.
Rommel DionisioCompass Point Research & Trading, LLC